Two posters demonstrated povorcitinib's durable 54-week efficacy and a favorable safety profile in moderate to severe HS, including patients previously on anti-TNF therapy. HS, a chronic, recurrent ...
Josh Heupel and the Tennessee Volunteers may come up short for a player that they previously looked like a lock to land. Josh Heupel and the Tennessee Vols have been on a recruiting hot streak over ...
An anti-ICE rioter who allegedly sank his teeth into federal law enforcement officers during a protest at Delaney Hall last week was previously accused of distributing child pornography. The New ...
A new study suggests using body mass index alone may miss many people with the disease, but the findings come with caveats. By Nina Agrawal See more of our coverage in your search results.Encuentra ...
Teclistamab is associated with better progression-free (PFS) and overall survival (OS) than standard regimens for relapsed or refractory multiple myeloma, according to the results of the first phase 3 ...
In a filing with the U.S. Securities and Exchange Commission (SEC), SpaceX has revealed that it holds 18,712 bitcoin, currently worth around $1.45 billion. Although Elon Musk previously revealed that ...
Middle East supply disruptions and Hormuz tensions are pushing major oil companies back toward politically stable regions like Alaska, reviving interest in projects once seen as too costly or ...
President Donald Trump and Defense Secretary Pete Hegseth on Friday released dozens of previously classified files on alleged UFO sightings and alien life to provide what they called “unprecedented ...
LOWELL — A Lowell man who previously served prison time for firing multiple rounds into an occupied vehicle in Cambridge — and who was still on probation for that case — was arrested again this month ...
A missing American woman’s husband previously threatened to throw her overboard before her sudden disappearance in the Bahamas, her daughter has claimed. Karli Aylesworth believes “something might ...
An FDA NDA for bezuclastinib in post-imatinib GIST was submitted under Real-Time Oncology Review, supported by earlier breakthrough therapy designation. PEAK randomized patients to bezuclastinib plus ...
Independent news. Trusted by Texans. About The Texas Tribune | Staff | Contact | Send a Confidential Tip | Ethics | Republish Our Work | Jobs | Awards | Corrections | Strategic Plan | Downloads | ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results